Ata-Ali J, Ata-Ali F, Di-Benedetto N, Bag‡n L, Bag‡n JV. Does HIV infection have an impact upon dental implant osseointegration? A systematic review. Med Oral Patol Oral Cir Bucal. 2015 May 1;20 (3):e347-56.

 

 

doi:10.4317/medoral.20408

http://dx.doi.org/doi:10.4317/medoral.20408

 

 

 

1. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011. Geneve: UNAIDS; 2011 [Accessed February 2014]. Available at: http://www.who.int/hiv/pub/progress_report2011/en.

 

2. Weiss RA. How does HIV cause AIDS?. Science. 1993;260:1273-9.
http://dx.doi.org/10.1126/science.8493571

 

3. Douek DC, Roederer M, Koup RA. Emerging Concepts in the Immunopathogenesis of AIDS. Annu Rev Med. 2009;60:471-84.
http://dx.doi.org/10.1146/annurev.med.60.041807.123549

 

4. Thompson MA, Aberg JA, Hoy JF, Telenti A, Benson C, Cahn P, et al. Antiretroviral Treatment of Adult HIV Infection 2012 Recommendations of the International Antiviral Society–USA Panel. JAMA. 2012;308:387-402.
http://dx.doi.org/10.1001/jama.2012.7961

 

5. Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853-60.
http://dx.doi.org/10.1056/NEJM199803263381301

 

6. Palella FJ, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV Outpatient Study. J Acquir Immune Defic Syndr. 2006;43:27-34.
http://dx.doi.org/10.1097/01.qai.0000233310.90484.16

 

7. Egger M, May M, Chne G, Phillips AN, Ledergerber B, Dabis F, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002;360:119-29.
http://dx.doi.org/10.1016/S0140-6736(02)09411-4

 

8. Chu C, Selwyn PA. An epidemic in evolution: the need for new models of HIV care in the chronic disease era. Journal of Urban Health. 2011;88:556-66.
http://dx.doi.org/10.1007/s11524-011-9552-y

 

9. Borderia M, Gibellinib D, Vescinic F, De Crignis E, Cimatti L, Biagetti C, et al. Metabolic bone disease in HIV infection. AIDS. 2009;23:1297-310.
http://dx.doi.org/10.1097/QAD.0b013e32832ce85a

 

10. Candel-Marti ME, Ata-Ali J, Pe-arrocha-Oltra D, Pe-arrocha-Diago M, Bag‡n JV. Dental implants in patients with oral mucosal alterations: An update. Med Oral Patol Oral Cir Bucal. 2011;16:e787-93.
http://dx.doi.org/10.4317/medoral.17056

 

11. Buser D, von Arx T, Bruggenkate C, Weingart D. Basic surgical principles with ITI implants. Clin Oral Implants Res. 2000;11:59-68.
http://dx.doi.org/10.1034/j.1600-0501.2000.011S1059.x

 

12. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264-9.
http://dx.doi.org/10.7326/0003-4819-151-4-200908180-00135

 

13. Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73:712-6.
http://dx.doi.org/10.1046/j.1445-2197.2003.02748.x

 

14. Romanos GE, Goldin E, Marotta L, Froum S, Tarnow DP. Immediate loading with fixed implant-supported restorations in an edentulous patient with an HIV infection: a case report. Implant Dent. 2014;23:8-12.
http://dx.doi.org/10.1097/ID.0b013e3182a62766

 

15. Shetty K, Achong R. Dental implants in the HIV-positive patient--case report and review of the literature. Gen Dent. 2005;53:434-7.

 

16. Baron M, Gritsch F, Hansy AM, Haas R. Implants in an HIV-positive patient: a case report. Int J Oral Maxillofac Implants. 2004;19:425-30.
http://dx.doi.org/10.1016/j.prosdent.2004.08.006

 

17. Rajnay ZW, Hochstetter RL. Immediate placement of an endosseous root-form implant in an HIV-positive patient: report of a case. J Periodontol. 1998;69:1167-71.
http://dx.doi.org/10.1902/jop.1998.69.10.1167

 

18. Kolhatkar S, Khalid S, Rolecki A, Bhola M, Winkler JR. Immediate dental implant placement in HIV-positive patients receiving highly active antiretroviral therapy: a report of two cases and a review of the literature of implants placed in HIV-positive individuals. J Periodontol. 2011;82:505-11.
http://dx.doi.org/10.1902/jop.2010.100433

 

19. Strietzel FP, Rothe S, Reichart PA, Schmidt-Westhausen AM. Implant-prosthetic treatment in HIV-infected patients receiving highly active antiretroviral therapy: report of cases. Int J Oral Maxillofac Implants. 2006;21:951-6.

 

20. Achong RM, Shetty K, Arribas A, Block MS. Implants in HIV-positive patients: 3 case reports. J Oral Maxillofac Surg. 2006;64:1199-203.
http://dx.doi.org/10.1016/j.joms.2006.04.037

 

21. Stevenson GC, Riano PC, Moretti AJ, Nichols CM, Engelmeier RL, Flaitz CM. Short-term success of osseointegrated dental implants in HIV-positive individuals: a prospective study. J Contemp Dent Pract. 2007;8:1-10.

 

22. Oliveira MA, Gallottini M, Pallos D, Maluf PS, Jablonka F, Ortega KL. The success of endosseous implants in human immunodeficiency virus-positive patients receiving antiretroviral therapy: a pilot study. J Am Dent Assoc. 2011;142:1010-6.
http://dx.doi.org/10.14219/jada.archive.2011.0320

 

23. OCEBM Levels of Evidence Working Group.The Oxford 2011 Levels of Evidence.Oxford Centre for Evidence-Based Medicine. Available at: http://www.cebm.net/index.aspx?o=1025. Accessed 14 April, 2014.

 

24. Astermark J, Lšfqvist T, Schulman S, Stigendal L, Lethagen S, Nilsson IM, et al. Major surgery seems not to influence HIV disease progression in haemophilia patients. Br J Haematol. 1998;103:10-4.
http://dx.doi.org/10.1046/j.1365-2141.1998.00961.x

 

25. Phillips AM, Sabin CA, Ribbans WJ, Lee CA. Orthopaedic surgery in hemophilic patients with human immunodeficiency virus. Clin Orthop Relat Res. 1997;343:81-7.
http://dx.doi.org/10.1097/00003086-199710000-00016

 

26. Wexner SD, Smithy WB, Milsom JW, Dailey TH. The surgical management of anorectal diseases in AIDS and pre-AIDS patients. Dis Colon Rectum. 1986;29:719-23.
http://dx.doi.org/10.1007/BF02555318

 

27. Morandi E, Merlini D, Salvaggio A, Foschi D, Trabucchi E. Prospective study of healing time after hemorrhoidectomy: influence of HIV infection, acquired immunodeficiency syndrome, and anal wound infection. Dis Colon Rectum. 1999;42:1140-4.
http://dx.doi.org/10.1007/BF02238565

 

28. Deneve JL, Shantha JG, Page AJ, Wyrzykowski AD, Rozycki GS, Feliciano DV. CD4 count is predictive of outcome in HIV-positive patients undergoing abdominal operations. Am J Surg. 2010;200:694-9.
http://dx.doi.org/10.1016/j.amjsurg.2010.07.030

 

29. Albaran RG, Webber J, Steffes CP. CD4 cell counts as a prognostic factor of major abdominal surgery in patients infected with the human immunodeficiency virus. Arch Surg. 1998;133:626-31.
http://dx.doi.org/10.1001/archsurg.133.6.626

 

30. Emparan C, Iturburu IM, Ortiz J, Mendez JJ. Infective complications after abdominal surgery in patients infected with human immunodeficiency virus: role of CD4+ lymphocytes in prognosis. World J Surg. 1998;22:778-82.
http://dx.doi.org/10.1007/s002689900469

 

31. Horberg MA, Hurley LB, Klein DB, Follansbee SE, Quesenberry C, Flamm JA, et al. Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Arch Surg. 2006;141:1238-45.
http://dx.doi.org/10.1001/archsurg.141.12.1238

 

32. Watts DH, Lambert JS, Stiehm ER, Bethel J, Whitehouse J, Fowler MG, et al. Complications according to mode of delivery among human immunodeficiency virus-infected women with CD4 lymphocyte counts of < or = 500/microL. Am J Obstet Gynecol. 2000;183:100-7.

 

33. Filsoufi F, Salzberg SP, Harbou KT, Neibart E, Adams DH. Excellent outcomes of cardiac surgery in patients infected with HIV in the current era. Clin Infect Dis. 2006;43:532-6.
http://dx.doi.org/10.1086/505977

 

34. Subramanian A, Sulkowski M, Barin B, Stablein D, Curry M, Nissen N, et al. MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates. Gastroenterology. 2010;138:159-64.
http://dx.doi.org/10.1053/j.gastro.2009.09.053

 

35. Arnsten JH, Freeman R, Howard AA, Floris-Moore M, Lo Y, Klein RS. Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS. 2007;21:617-23.
http://dx.doi.org/10.1097/QAD.0b013e3280148c05

 

36. Allison GT, Bostrom MP, Glesby MJ. Osteonecrosis in HIV disease: epidemiology, etiologies, and clinical management. AIDS. 2003;17:1-9.
http://dx.doi.org/10.1097/00002030-200301030-00003

 

37. Bonjoch A, Figueras M, Estany C, Perez-Alvarez N, Rosales J, del Rio L, et al. High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study. AIDS. 2010;24:2827.
http://dx.doi.org/10.1097/QAD.0b013e328340a28d

 

38. Slagter KW, Raghoebar GM, Vissink A. Osteoporosis and edentulous jaws. Int J Prosthodont. 2008;21:19-26.

 

39. Amorim MA, Takayama L, Jorgetti V, Pereira RM. Comparative study of axial and femoral bone mineral density and parameters of mandibular bone quality in patients receiving dental implants. Osteoporos Int. 2007;18:703-9.
http://dx.doi.org/10.1007/s00198-006-0295-7

 

40. Friberg B, Ekestubbe A, Mellstršm D, Sennerby L. BrŒnemark implants and osteoporosis: a clinical exploratory study. Clin Implant Dent Relat Res. 2001;3:50-6.
http://dx.doi.org/10.1111/j.1708-8208.2001.tb00128.x

 

41. Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS. 2006;20:2165.
http://dx.doi.org/10.1097/QAD.0b013e32801022eb

 

42. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med. 1995;332:305-11.
http://dx.doi.org/10.1056/NEJM199502023320506

 

43. Gibellini D, De Crignis E, Ponti C, Cimatti L, Borderi M, Tschon M, et al. HIV-1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNF alpha activation. J Med Virol. 2008;80:1507-14.
http://dx.doi.org/10.1002/jmv.21266

 

44. Goss A, Bartold M, Sambrook P, Hawker P. The nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in dental implant patients: a South Australian case series. J Oral Maxillofac Surg. 2010;68:337-43.
http://dx.doi.org/10.1016/j.joms.2009.09.037

 

45. Ata-Ali F, Ata-Ali J, Flichy-Fern‡ndez AJ, Bagan JV. Osteonecrosis of the jaws in patients treated with bisphosphonates. J Clin Exp Dent. 2012;4:e60-5.
http://dx.doi.org/10.4317/jced.50649

 

46. Siebert T, Jurkovic R, Statelova D, Strecha J. Immediate implant placement in and a patient with osteoporosis undergoing patient using bisphosphonate therapy: 1- year preliminary prospective study. J Oral Implantol. Epub ahead of print 2013.

 

47. Grant BT, Amenedo C, Freeman K, Kraut RA. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases. J Oral Maxillofac Surg. 2008;66:223-30.
http://dx.doi.org/10.1016/j.joms.2007.09.019

 

48. Koka S, Babu NM, Norell A. Survival of dental implants in post-menopausal bisphosphonate users. J Prosthodont Res. 2010;54:108-11.
http://dx.doi.org/10.1016/j.jpor.2010.04.002

 

49. Ata-Ali J, Ata-Ali F, Ata-Ali F. Do antibiotics decrease implant failure and postoperative infections? A systematic review and meta-analysis. Int J Oral Maxillofac Surg. 2014;43:68-74.
http://dx.doi.org/10.1016/j.ijom.2013.05.019